Last reviewed · How we verify

NCT07333989

Effect of Biofeedback Activation on Balance in Osteoporotic Elderly

Recruiting now NA Last updated 20 March 2026
What this trial tests

NA trial testing Electromyographic (EMG) biofeedback in Balance Problems in 60 participants. Currently enrolling.

Timeline
2 January 2026
Primary endpoint
5 April 2026
1 May 2026

Quick facts

Lead sponsorMohamed Said Alsafy Alhamrawy
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date2 January 2026
Primary completion5 April 2026
Estimated completion1 May 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mohamed Said Alsafy Alhamrawy

Who can join

Adults 65 to 75, any sex, with Balance Problems or Elderly (People Aged 65 or More). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate the effect of gluteus medius activation using electromyography (EMG) biofeedback combined with balance training on balance, physical performance, gluteus medius muscle activity, and quality of life in osteoporotic elderly patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Electromyographic (EMG) biofeedback

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07333989.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing